Cipla Ltd.

BSE: 500087 | NSE: CIPLA

Large Cap | Pharmaceuticals & Drugs

1438.75

-2.95 (-0.20%)

< Home < Back

Cipla submits press release

Date: 22-07-2019

Cipla has informed about submission of press release dated 22nd July, 2019 regarding its wholly owned step down subsidiary lnvaGen Pharmaceuticals Inc. receives final approval for generic version of Pfizer's Lyrica (Pregabalin Capsules, 25mg, 50mg, 75mg, 100 mg, 150mg, 200mg, 225mg, 300mg).

The above information is a part of company’s filings submitted to BSE.